LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Healthcare Conference on Tuesday, May 6, 2008. Michael G. Kauffman, M.D., Ph.D., chief executive officer of EPIX, is scheduled to discuss the company’s business strategy and corporate overview at 1:30 p.m. (ET) at the InterContinental in Boston.
